WIOLETTA SKRODZKA: Open Payments
NPI 1184337123 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 34 payments from 12 companies in 2025. Trend: 2023 $573 · 2024 $429 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $247 |
| Amgen Inc. | 3 | $157 |
| ABBVIE INC. | 10 | $147 |
| Novo Nordisk Inc | 3 | $86 |
| Lilly USA, LLC | 3 | $56 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: FARXIGA, VRAYLAR, Repatha, BREZTRI, MOUNJARO, TRELEGY ELLIPTA, OTEZLA, Ozempic.
Industry payments across CT — which companies pay providers there.
